.7 Brudzynski, S. M.; Mogenson, G. J. Association of the mesen- 22.
cephalic locomotor region with locomotor activity induced by in- jection of amphetamine into the nucleus accumbens. Brain Res.
334:77-84; 1985. 23.
4. Brudzynski, S. M.; Wu, M.; Mogenson, G. J. Decreases in rat lo- comotor activity as a result of changes in synaptic transmission to
neurons within the mesencephalic locomotor region. Can. J. Physiol. 24.
Pharmacol. 7 I :394-406; 1993.
5. Cohn, D. V.; Zangerle, R.; Fischer-Colbrie, R.; Chu, L. L.; Elting,
J. J.; Hamilton, J. W.; Winkler, H. Similarity of secretory protein I
from parathyroid gland to chromogranin A from adrenal medulla. 25.
Proc. Natl. Acad. Sci. USA 79:6056-6059; 1982.
6. Donzanti, B. A.; Uretsky, N. J. Effects of excitatory amino acid on
locomotor activity after bilateral microinjection into the rat nucleus
accumbens: Possible dependence on dopaminergic mechanism. Neu- 26.
ropharmacology 22:97 l-981 ; 1983.
7. Efendic, S.; Tatemoto, K.; Mutt, V.; Quan, C.; Chang. D.; Ostenson,

C. G. Pancreastatin and islet hormone release. Proc. Nat]. Acad. Sci. 27.
USA 84:7257-7260; 1987.
8. Fasciotto, B. H.; Gorr, S. U.; Bourdeau, A. M.; Cohn, D. V. Autocrine regulation of parathyroid secretion: Inhibition of secretion by

chromogranin-A (secretory protein-l) and potentiation of secretion 28.
by chromogranin-A and pancreastatin antibodies. Endocrinology
127:1329-1335; 1990.
9. Galindo, E.; Mendez, M.; Calvo. S.; Gonzalez-Garcia, C.; Cena,
V.; Hubert, P.; Bader, M. F.; Aunis, D. Chromostatin receptors con-29.
trol calcium channel activity in adrenal chromaffin cells. J. Biol.
Chem. 267:407-412; 1992.
30.
IO. Galindo, E.; Rill, A.; Bader, M. F.; Aunis, D. Chromostatin, a 20- amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion. Proc. Natl. Acad. Sci. USA 88: 1426- 1430;
31.
1991.
II. Gibson, C. J.; Munoz, D. G. Chromogranin A inhibits retinal do- pamine release. Brain Res. 622:303-306; 1993.
32.
12. Gorr, S. U.; Dean, W. L.; Radley, T. L.; Cohn, D. V. Calciumbinding and aggregation properties of parathyroid secretory protein- I (chromogranin A). Bone Miner. 4:17-25; 1988.
13. Hagiwara, S.; Byerly, L. Calcium channel. Annu. Rev. Neurosci.
33.
4:69-125; 1981.
14. Heinicke, E.; Kumar, U.; Munoz, D. G. Quantitative dot-blot assay
34.
for proteins using enhanced chemiluminescence. J. Immunol. Methods 152:227-236; 1992.
15. Helman, L. J.; Ahn, T. G.; Levine, M. A.; Allison, A.; Cohen, P. S.;
35.
Cooper, M. J.; Cohn, D. V.; Israel, M. A. Molecular cloning and
primary structure of human chromogranin A (secretory protein I)
cDNA. J. Biol. Chem. 263:11559- 11563; 1988.
36.
16. Herzig, K. H.; Louie, D. S.; Tatemoto, K.; Chung, 0. Y. Pancreastatin inhibits pancreatic enzyme secretion by presynaptic
modulation of acetylcholine release. Am. J. Physiol. 262:Gll3-37.
G117; 1992.
17. Imperato, A.; Honore, T.; Jensen, L. H. Dopamine release in the
nucleus caudatus and in the nucleus accumbens is under glutama-38.
tergic control through non-NMDA receptors: A study in freely-moving rats. Brain Res. 530:223-228; 1990.
18. Ishizuka, J.; Tatemoto, K.; Cohn, D. V.; Thompson, J. C.; Greeley,
39.
G. H. J. Effects of pancreastatin and chromogranin A on insulin
release stimulated by various insulinotropic agents. Regul. Pept.
34:25-32; 1991.
19. Jones, D. L.; Mogenson, G. J. Nucleus accumbens to globus pallidus
GABA projection subserving ambulatory activity. Am. J. Physiol.
40.
238:R65-R69; 1980.
20. Kar. S.; Bretherton-Watt, D.; Gibson, S. J.; Steel, J. H.; Gentleman,
S. M.; Roberts, G. W.; Valentino, K.; Tatemoto, K.; Ghatei, M. A.;
Bloom, S. R.; et al. Novel peptide pancreastatin: Its occurrence and 41.
codistribution with chromogranin A in the central nervous system
42
of the pig. J. Comp. Neurolr 288:627-639; 1989.
21. Kelly, P. H.; Seviour, P. W.; Iversen, S. D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nu- 43.
cleus accumbens septi and corpus striatum. Brain Res. 94:507-522;
1975.
